Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Open House Pharmaceutical Discount Contracts For The Active Ingredient Lamivudine, Abacavir And Dolutegravir, Atc J05Ar13

AOK Rheinland-Pfalz Saarland - Die Gesundheitskasse Germany has Released a tender for Open House Pharmaceutical Discount Contracts For The Active Ingredient Lamivudine, Abacavir And Dolutegravir, Atc J05Ar13 in Pharmaceuticals. The tender was released on Jul 14, 2025.

Country - Germany

Summary - Open House Pharmaceutical Discount Contracts For The Active Ingredient Lamivudine, Abacavir And Dolutegravir, Atc J05Ar13

Deadline - Jun 30, 2027

GT reference number - 113307633

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 113307633

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Completion of non-exclusive discount contracts in accordance with Sections 130a (8/13) SGB V for medicinal products with the above-mentioned active ingredient from 01.09.2025 to 31.08.2027 with at any time of the contract (open house mod el). In the open house process, medicines are excluded according to the BfArM list according to § 35 Paragraph 5a SGB V (children's medicine).local title:: Open house Arzneimittelrabattverträge zum Wirkstoff Lamivudin, Abacavir und Dolutegravir, ATC J05AR13Contract Type: : Supplylocal description: : Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit o.g. Wirkstoff innerhalb des Zeitraumes

Gt Ref Id - 113307633

Deadline - Jun 30, 2027

Share share

Similar Tenders :

Summary:
Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database